Ghent University Academic Bibliography

Mark

Effect of early and systematic integration of palliative care in patients with advanced cancer : a randomised controlled trial

Gaëlle Vanbutsele (UGent) , Koen Pardon (UGent) , Simon Van Belle (UGent) , Veerle Surmont (UGent) , Martine De Laat (UGent) , Roos Colman (UGent) , Kim Eecloo (UGent) , Veronique Cocquyt (UGent) , Karen Geboes (UGent) and Luc Deliens (UGent)

(2018) LANCET ONCOLOGY. 19(3). p.394-404

Mark

A gene-expression profiling score for prediction of outcome in patients with follicular lymphoma : a retrospective training and validation analysis in three international cohorts

Sarah Huet, Bruno Tesson, Jean-Philippe Jais, Andrew L Feldman, Laura Magnano, Emilie Thomas, Alexandra Traverse-Glehen, Benoit Albaud, Marjorie Carrere, Luc Xerri, et al.

(2018) LANCET ONCOLOGY. 19(4). p.549-561

Mark

Effect of early palliative care : complex intervention and complex results : authors' reply

Gaëlle Vanbutsele (UGent) , Koen Pardon (UGent) , Simon Van Belle (UGent) , Veerle Surmont (UGent) , Martine De Laat (UGent) , Roos Colman (UGent) , Kim Eecloo (UGent) , Veronique Cocquyt (UGent) , Karen Geboes (UGent) and Luc Deliens (UGent)

(2018) LANCET ONCOLOGY. 19(5). p.e222-e222

Mark

Definition and recommendations for advance care planning : an international consensus supported by the European Association for Palliative Care

Judith AC Rietjens, Rebecca L Sudore, Michael Connolly, Johannes J van Delden, Margaret A Drickamer, Mirjam Droger, Agnes van der Heide, Daren K Heyland, Dirk Houttekier (UGent) , Daisy JA Janssen, et al.

(2017) LANCET ONCOLOGY. 18(9). p.e543-e551

Mark

journalArticle
A1
open access

First-line selective internal radiotherapy plus chemotherapy versus chemotherapy alone in patients with liver metastases from colorectal cancer (FOXFIRE, SIRFLOX, and FOXFIRE-Global) : a combined analysis of three multicentre, randomised, phase 3 trials

Harpreet S Wasan, Peter Gibbs, Navesh K Sharma, Julien Taieb, Volker Heinemann, Jens Ricke, Marc Peeters, Michael Findlay, Andrew Weaver, Jamie Mills, et al.

(2017) LANCET ONCOLOGY. 18(9). p.1159-1171

Mark

journalArticle
A1
open access

Concurrent once-daily versus twice-daily chemoradiotherapy in patients with limited-stage small-cell lung cancer (CONVERT) : an open-label, phase 3, randomised, superiority trial

Corinne Faivre-Finn, Michael Snee, Linda Ashcroft, Wiebke Appel, Fabrice Barlesi, Adityanarayan Bhatnagar, Andrea Bezjak, Felipe Cardenal, Pierre Fournel, Susan Harden, et al.

(2017) LANCET ONCOLOGY. 18(8). p.1116-1125

Mark

Busulfan and melphalan versus carboplatin, etoposide, and melphalan as high-dose chemotherapy for high-risk neuroblastoma (HR-NBL1/SIOPEN) : an international, randomised, multi-arm, open-label, phase 3 trial

Ruth Ladenstein, Ulrike Pötschger, Andrew D. J. Pearson, Penelope Brock, Roberto Luksch, Victoria Castel, Isaac Yaniv, Vassilios Papadakis, Genevieve Laureys (UGent) , Josef Malis, et al.

(2017) LANCET ONCOLOGY. 18(4). p.500-514

Mark

Ibrutinib combined with bendamustine and rituximab compared with placebo, bendamustine, and rituximab for previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (HELIOS): a randomised, double-blind, phase 3 study

A Chanan-Khan, P Cramer, F Demirkan, G Fraser, RS Silva, S Grosicki, A Pristupa, A Janssens, J Mayer, NL Bartlett, et al.

(2016) LANCET ONCOLOGY. 17(2). p.200-211

Mark

Carfilzomib and dexamethasone versus bortezomib and dexamethasone for patients with relapsed or refractory multiple myeloma (ENDEAVOR) : a randomised, phase 3, open-label, multicentre study

Meletios A Dimopoulos, Philippe Moreau, Antonio Palumbo, Douglas Joshua, Ludek Pour, Roman Hájek, Thierry Facon, Heinz Ludwig, Albert Oriol, Hartmut Goldschmidt, et al.

(2016) LANCET ONCOLOGY. 17(1). p.27-38

Mark

misc

Global task force on radiotherapy for cancer control

David A Jaffray, Felicia M Knaul, Rifat Atun, Cary Adams, Michael B Barton, Michael Baumann, Yolande Lievens (UGent) , Tracey YM Lui, Danielle L Rodin, Eduardo Rosenblatt, et al.

(2015) LANCET ONCOLOGY. 16(10). p.1144-1146

Academic Bibliography

Effect of early and systematic integration of palliative care in patients with advanced cancer : a randomised controlled trial

A gene-expression profiling score for prediction of outcome in patients with follicular lymphoma : a retrospective training and validation analysis in three international cohorts

Effect of early palliative care : complex intervention and complex results : authors' reply

Definition and recommendations for advance care planning : an international consensus supported by the European Association for Palliative Care

First-line selective internal radiotherapy plus chemotherapy versus chemotherapy alone in patients with liver metastases from colorectal cancer (FOXFIRE, SIRFLOX, and FOXFIRE-Global) : a combined analysis of three multicentre, randomised, phase 3 trials

Concurrent once-daily versus twice-daily chemoradiotherapy in patients with limited-stage small-cell lung cancer (CONVERT) : an open-label, phase 3, randomised, superiority trial

Busulfan and melphalan versus carboplatin, etoposide, and melphalan as high-dose chemotherapy for high-risk neuroblastoma (HR-NBL1/SIOPEN) : an international, randomised, multi-arm, open-label, phase 3 trial

Ibrutinib combined with bendamustine and rituximab compared with placebo, bendamustine, and rituximab for previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (HELIOS): a randomised, double-blind, phase 3 study

Carfilzomib and dexamethasone versus bortezomib and dexamethasone for patients with relapsed or refractory multiple myeloma (ENDEAVOR) : a randomised, phase 3, open-label, multicentre study

Global task force on radiotherapy for cancer control

Contents

Support

Contact